FILINGS
APLS 0001492422 | |||
---|---|---|---|
Filing Date | Form Type | Description | Document |
2019-05-07 | 10-Q | 10-Q | View Document |
2019-04-30 | DEFA14A | DEFA14A | View Document |
2019-04-30 | DEF 14A | DEF 14A | View Document |
2019-04-15 | 3 | FORM 3 SUBMISSION | View Document |
2019-04-15 | 3 | FORM 3 SUBMISSION | View Document |
2019-04-15 | 3 | FORM 3 SUBMISSION | View Document |
2019-04-12 | 8-K | 8-K | View Document |
2019-03-22 | SC 13G/A | SC 13G/A | View Document |
2019-03-13 | SC 13G/A | SC 13G/A | View Document |
2019-03-13 | 4 | 4 | View Document |
2019-03-07 | 424B5 | 424B5 | View Document |
2019-03-07 | 8-K | 8-K | View Document |
2019-03-06 | 424B5 | 424B5 | View Document |
2019-03-04 | 8-K | FORM 8-K | View Document |
2019-02-28 | 8-K | 8-K | View Document |
2019-02-26 | POS AM | POS AM | View Document |
2019-02-26 | 10-K | 10-K | View Document |
2019-02-26 | POSASR | POSASR | View Document |
2019-02-26 | S-8 | S-8 | View Document |
2019-02-14 | SC 13G/A | AMENDMENT NO. 2 | View Document |
2019-02-14 | SC 13G/A | APELLIS PHARMACEUTICALS, INC. | View Document |
2019-02-14 | SC 13G/A | APELLIS PHARMACEUTICALS, INC. | View Document |
2019-02-14 | SC 13G/A | VENBIO GLOBAL STRATEGIC FUND II, L.P. / APELLIS PHARMACEUTICALS - SCHEDULE 13G/A | View Document |
2019-02-14 | SC 13G | SC 13G | View Document |
2019-02-12 | 4 | FORM 4 SUBMISSION | View Document |
2019-02-12 | 4 | FORM 4 SUBMISSION | View Document |
2019-02-12 | 4 | FORM 4 SUBMISSION | View Document |
2019-02-12 | 4 | FORM 4 SUBMISSION | View Document |
2019-02-12 | 4 | FORM 4 SUBMISSION | View Document |
2019-02-12 | 4 | FORM 4 SUBMISSION | View Document |
2019-02-12 | 4 | FORM 4 SUBMISSION | View Document |
2019-02-08 | SC 13G | View Document | |
2019-01-03 | 4 | FORM 4 SUBMISSION | View Document |
2019-01-03 | 4 | FORM 4 SUBMISSION | View Document |
2019-01-03 | 4 | FORM 4 SUBMISSION | View Document |
2019-01-03 | 4 | FORM 4 SUBMISSION | View Document |
2018-12-28 | S-3ASR | S-3ASR | View Document |
2018-12-20 | 8-K | 8-K | View Document |
2018-11-15 | 4 | PRIMARY DOCUMENT | View Document |
2018-11-15 | 4 | PRIMARY DOCUMENT | View Document |
2018-11-13 | 10-Q | 10-Q | View Document |
2018-10-17 | 8-K | FORM 8-K | View Document |
2018-09-24 | 4 | FORM 4 SUBMISSION | View Document |
2018-09-19 | 4 | FORM 4 SUBMISSION | View Document |
2018-09-17 | 4 | FORM 4 SUBMISSION | View Document |
2018-09-04 | 8-K | FORM 8-K | View Document |
2018-07-31 | 10-Q | 10-Q | View Document |
2018-06-05 | 8-K | FORM 8-K | View Document |
2018-05-30 | 4 | FORM 4 SUBMISSION | View Document |
2018-05-29 | 4 | FORM 4 SUBMISSION | View Document |
2018-05-09 | 4 | FORM 4 SUBMISSION | View Document |
2018-05-09 | 4 | FORM 4 SUBMISSION | View Document |
2018-05-09 | 4 | FORM 4 SUBMISSION | View Document |
2018-05-09 | 4 | FORM 4 SUBMISSION | View Document |
2018-05-09 | 4 | FORM 4 SUBMISSION | View Document |
2018-04-30 | 10-Q | 10-Q | View Document |
2018-04-25 | DEFA14A | DEFA14A | View Document |
2018-04-25 | DEF 14A | DEF 14A | View Document |
2018-04-19 | 424B4 | 424B4 | View Document |
2018-04-18 | EFFECT | View Document | |
2018-04-18 | S-1MEF | S-1MEF | View Document |
2018-04-17 | 4 | FORM 4 SUBMISSION | View Document |
2018-04-17 | 3 | FORM 3 SUBMISSION | View Document |
2018-04-16 | CORRESP | View Document | |
2018-04-16 | CORRESP | View Document | |
2018-04-16 | S-1 | S-1 | View Document |
2018-04-12 | 4 | FORM 4 SUBMISSION | View Document |
2018-04-06 | UPLOAD | View Document | |
2018-04-03 | DRS | View Document | |
2018-04-02 | 8-K | FORM 8-K | View Document |
2018-03-19 | 10-K | 10-K | View Document |
2018-02-21 | 4 | FORM 4 SUBMISSION | View Document |
2018-02-21 | 4 | FORM 4 SUBMISSION | View Document |
2018-02-21 | 4 | FORM 4 SUBMISSION | View Document |
2018-02-21 | 4 | FORM 4 SUBMISSION | View Document |
2018-02-21 | 4 | FORM 4 SUBMISSION | View Document |
2018-02-21 | 4 | FORM 4 SUBMISSION | View Document |
2018-02-21 | 4 | FORM 4 SUBMISSION | View Document |
2018-02-14 | SC 13G/A | View Document | |
2018-02-14 | SC 13G | APELLIS PHARMACEUTICALS, INC. | View Document |
2018-02-14 | SC 13G | SC 13G | View Document |
2018-02-09 | SC 13G | VENBIO GLOBAL STRATEGIC FUND II, L.P. / APELLIS PHARMACEUTICALS - SCHEDULE 13G | View Document |
2018-02-08 | SC 13G | SCHEDULE 13G | View Document |
2017-12-20 | 10-Q | 10-Q | View Document |
2017-11-21 | SC 13G | View Document | |
2017-11-15 | 4 | HILLHOUSE CAPITAL MANAGEMENT, LTD. | View Document |
2017-11-14 | 4 | FORM 4 | View Document |
2017-11-13 | S-8 | S-8 | View Document |
2017-11-13 | 4 | FORM 4 SUBMISSION | View Document |
2017-11-13 | 4 | FORM 4 SUBMISSION | View Document |
2017-11-13 | 4 | FORM 4 SUBMISSION | View Document |
2017-11-13 | 4 | FORM 4 SUBMISSION | View Document |
2017-11-13 | 4 | FORM 4 SUBMISSION | View Document |
2017-11-13 | 8-K | FORM 8-K | View Document |
2017-11-09 | 424B4 | 424B4 | View Document |
2017-11-08 | EFFECT | View Document | |
2017-11-08 | 3 | FORM 3 SUBMISSION | View Document |
2017-11-08 | 3 | FORM 3 SUBMISSION | View Document |
2017-11-08 | 3 | FORM 3 SUBMISSION | View Document |
2017-11-08 | 3 | FORM 3 SUBMISSION | View Document |
Search company filings and access detailed reports including 10-K, 10-Q, 8-K, and other critical filings. Stay informed on corporate disclosures, regulatory filings, and updates with our easy-to-use EDGAR API filings search tool.